Easypod Auto Injector, model 5.1 (Used to inject SAIZEN growth hormone under the skin) 의 리콜

Department of Health, Therapeutic Goods Administration에 따르면, 해당 리콜 는 Australia 에서 Merck Serono Australia Pty Ltd 에 의해 제조된 제품과 관련되어 있습니다.

이것은 무엇인가요?

의료기기에 문제가 생겼을 경우 제조사가 이를 바로잡거나 시장에서 회수하는 조치를 말한다. 회수(Recall)는 의료기기에 결함이 있거나, 건강에 위협이 되거나, 또는 결함도 있고 건강에도 위협이 될 경우에 발생한다.

데이터에 대해 더 자세히 알아보기 여기
  • 사례 유형
    Recall
  • 사례 ID
    RC-2013-RN-00908-1
  • 사례 위험등급
    Class II
  • 사례 시작날짜
    2013-09-04
  • 사례 국가
  • 사례 출처
    DHTGA
  • 사례 출처 URL
  • 비고 / 경고
    Australian data is current through July 2018. All of the data comes from the Australian Therapeutic Goods Administration, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and Australia.
  • 데이터 추가 비고
  • 원인
    The easypod injection device requires programming prior to supply to ensure the patient receives the correct dose. with the interruption in the supply of saizen solution for injection, devices required reprogramming to take into consideration the change in concentration from either 5.83 mg/ml or 8 mg/ml available in the solution for injection presentations to only 5.83 mg/ml in the click.Easy powder for injection presentation. to mitigate against the risk of a patient receiving an incorrect dose due to their device not having been reprogrammed as required, merck serono is recalling the current easypod device and replacing it with a new model. the newer model (model 5.2) will not proceed to injection if the cartridge in the device does not match the programmed settings. further, this feature cannot be over-ridden by the patient representing an improvement on the cartridge recognition feature in the current model (model 5.1).
  • 조치
    Merck Serono is contacting clinicians and pharmacists of patients under the PBS Growth Hormone Program for replacing the Easypod auto injector model 5.1 with model 5.2. Merck Serono is contacting private patients affected and asking them to get the replacement devices from their pharmacies. In the meantime, customers are asked not to stop using SAIZEN and continue with the treatment as directed by their doctor. For more details, please see http://www.tga.gov.au/safety/alerts-device-easypod-auto-injector-130906.htm .

Device

  • 모델명 / 제조번호(시리얼번호)
    Easypod Auto Injector, model 5.1 (Used to inject SAIZEN growth hormone under the skin)ARTG Number: 168234
  • Manufacturer

Manufacturer